The EGFR-Y1173-phospholipase C gamma (PLCγ)-DAG axis induces the activation of PKCδ, which is related to cancer cell proliferation, and a potent therapeutic target in EGFR-mutant NSCLC cells [29]. This evidence concerns the gene EGFR and cancer.